| Nanotechnology based drug delivery systems: Does shape really matter? S Shah, P Famta, D Bagasariya, K Charankumar, E Amulya, DK Khatri, ... International Journal of Pharmaceutics 625, 122101, 2022 | 33 | 2022 |
| Advancements in redox-sensitive micelles as nanotheranostics: a new horizon in cancer management A Sikder, G Vambhurkar, E Amulya, D Bagasariya, P Famta, S Shah, ... Journal of Controlled Release 349, 1009-1030, 2022 | 31 | 2022 |
| Quality by design (QbD) assisted Fabrication & evaluation of Simvastatin loaded Nano-Enabled thermogel for melanoma therapy P Famta, S Shah, V Fernandes, KC Kumar, D Bagasariya, KS Samim, ... International journal of pharmaceutics 628, 122270, 2022 | 28 | 2022 |
| Quality by design steered development of Niclosamide loaded liposomal thermogel for Melanoma: In vitro and Ex vivo evaluation S Shah, P Famta, V Fernandes, D Bagasariya, K Charankumar, DK Khatri, ... European Journal of Pharmaceutics and Biopharmaceutics 180, 119-136, 2022 | 27 | 2022 |
| Tumor-promoting aftermath post-chemotherapy: A focus on breast cancer P Famta, S Shah, N Jain, KC Kumar, D Bagasariya, DK Khatri, ... Life sciences 310, 121125, 2022 | 23 | 2022 |
| Tuning mesoporous silica nanoparticles in novel avenues of cancer therapy S Shah, P Famta, D Bagasariya, K Charankumar, A Sikder, R Kashikar, ... Molecular Pharmaceutics 19 (12), 4428-4452, 2022 | 22 | 2022 |
| Quality by design (QbD) abetted development of pioglitazone incorporated liposomes-loaded hyaluronic acid-based in situ hydrogel for the management of melanoma K Charankumar, D Bagasariya, N Jain, P Famta, S Shah, G Vambhurkar, ... Journal of Drug Delivery Science and Technology 84, 104453, 2023 | 18 | 2023 |
| Quality by design endorsed fabrication of Ibrutinib-loaded human serum albumin nanoparticles for the management of leukemia P Famta, S Shah, G Vambhurkar, DA Srinivasarao, N Jain, N Begum, ... European Journal of Pharmaceutics and Biopharmaceutics 190, 94-106, 2023 | 15 | 2023 |
| Biomimetic nanotherapeutics: Employing nanoghosts to fight melanoma D Bagasariya, K Charankumar, S Shah, P Famta, DK Khatri, ... European Journal of Pharmaceutics and Biopharmaceutics 177, 157-174, 2022 | 15 | 2022 |
| Quality by design endorsed atorvastatin-loaded nanostructured lipid carriers embedded in pH-responsive gel for melanoma D Bagasariya, K Charankumar, S Shah, P Famta, V Fernandes, ... Journal of Microencapsulation 41 (1), 27-44, 2024 | 6 | 2024 |
| Quality by design accredited self-nanoemulsifying delivery of ibrutinib for extenuating the fast-fed variability, ameliorating the anticancer activity and oral bioavailability … S Shah, P Famta, G Vambhurkar, DA Srinivasarao, KC Kumar, ... Journal of Drug Delivery Science and Technology 89, 105052, 2023 | 5 | 2023 |
| Quality by design (QbD) commended exploration of bosutinib loaded lipid nanocarriers for food effect attenuation and bioavailability enhancement in breast cancer P Famta, S Shah, G Vambhurkar, DA Srinivasarao, D Bagasariya, ... Journal of Drug Delivery Science and Technology 90, 105180, 2023 | 4 | 2023 |
| Sulfo-butyl ether β-cyclodextrin inclusion complexes of bosutinib: in silico, in vitro and in vivo evaluation in attenuating the fast-fed variability S Shah, P Famta, G Vambhurkar, D Bagasariya, KC Kumar, ... Drug Delivery and Translational Research 14 (5), 1218-1231, 2024 | 3 | 2024 |
| Despicable role of epithelial–mesenchymal transition in breast cancer metastasis: Exhibiting de novo restorative regimens P Famta, S Shah, B Dey, KC Kumar, D Bagasariya, G Vambhurkar, ... Cancer Pathogenesis and Therapy 3 (01), 30-47, 2025 | 2 | 2025 |
| Amelioration of breast cancer therapies through normalization of tumor vessels and microenvironment: paradigm shift to improve drug perfusion and nanocarrier permeation P Famta, S Shah, G Vambhurkar, G Pandey, D Bagasariya, KC Kumar, ... Drug Delivery and Translational Research, 1-18, 2024 | 1 | 2024 |
| Polymers in advanced drug and gene delivery A Sikder, D Bagasariya, S Shah, P Famta, R Kashikar, AK Kotha, ... Polymers for Pharmaceutical and Biomedical Applications, 291-332, 2024 | 1 | 2024 |
Paras FamtaNational institute of pharmaceutical education and research, HyderabadVerified email at niperhyd.ac.in